Richard R. Furman MD
Oncology, Haematology
New York, New York, United States of America
Connect with the speaker?
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL and has played an integral part in the development of ibrutinib and idelalisib.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
Key Insights: Lymphoma and Myeloma 2018 - A Focus on Chronic Lymphocytic Leukemia
Webcast
Haematology ...
Oct 31, 2018 - Oct 31, 2019
Lymphoma & Myeloma Congress 2019
In-Person Event- Oncology ...
- Oct 23 - 26, 2019
New York City, New York, USA
Lymphoma & Myeloma 2018: An International Congress on Hematologic Malignancies
- In-Person Event
- Hematology Blood and Marrow Transplant ...
- Oct 17 - 20, 2018
- New York City, New York, USA
Great Debates and Updates in Hematologic Malignancies 2016
- In-Person Event
- Hematology Blood and Marrow Transplant
- Apr 01 - 02, 2016
- New york city, New York, USA
12th International Ultmann Chicago Lymphoma Symposium (IUCLS)
- In-Person Event
- Hematology Blood and Marrow Transplant ...
- Apr 24 - 25, 2015
- Chicago, Illinois, USA
Quick Links
Connect With Us
Awards & Recognitions
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com